COVID-19 Resources > COVID-19 Web Series FAQs > Clinical Concerns in Emergency Departments and Opioid Treatment Centers

ACMT COVID-19 Web Series FAQs

Clinical Concerns in Emergency Departments and Opioid Treatment Centers

As the COVID-19 pandemic spreads, several recurrent themes have been noted. Initially, there is a significant drop in total ED volume, followed by a surge of respiratory complaints. Depending on the availability, extent, and reliability of testing (particularly the adequacy of nasopharyngeal sampling), use of resources such as PPE, hospital beds, and staff allocation is mismatched to the need. Once the surge is well-established, advance triage, cohorting of patients by clinical diagnosis, and variably monitored discharge of symptomatic patients is required. The aftermath of ED avoidance, impact of the pandemic on delays in presentation for other urgent conditions, and persisting inadequacies of testing material, PPE, and healthy providers then follows. Can we do better in the next month(s) and what can we anticipate as the number of cases decrease?

 

FAQs - Clinical Concerns in Emergency Departments and Opioid Treatment Centers

Last updated: April 27, 2020
 What are some of the concerns (medical, emotional, other) for discharged patients after diagnosis or care for COVID-19? posted on 5:35 PM, April 28, 2020
 What has happened with other Emergency Department visits during the pandemic? posted on 5:32 PM, April 28, 2020
 What are reasonable guidelines for resuming face-to-face encounters for patients treated for substance misuse? posted on 5:24 PM, April 28, 2020
RSS rss